WebPrescriberPoint has dosing & prescribing resources for Aldurazyme. Free platform for providers, check interactions, prior auth forms, copay support & more. Aldurazyme … WebALDURAZYME ® (laronidase) is an enzyme replacement therapy designed to address the underlying cause of mucopolysaccharidosis I (MPS I). ALDURAZYME is manufactured by BioMarin and commercialized by Sanofi Genzyme in the US, EU, and internationally. MPS I is an inherited lysosomal storage disorder caused by a deficiency of alpha-L-iduronidase, …
SUMMARY OF PRODUCT CHARACTERISTICS
WebAldurazyme will be given once weekly by intravenous (IV) infusion, meaning that the medication is delivered directly into your bloodstream. An HCP will give you this infusion, which usually take 3 to 4 hours. hard card script
ALDURAZYME (Genzyme Corporation): FDA Package Insert
WebClinical Policy: Laronidase (Aldurazyme) Reference Number : CP.PHAR.152 Effective Date: 02.01.16 Last Review Date: 05.22 Line of Business: Commercial, HIM, Medicaid . Coding Implications ... age expansion, new dosing regimen) that is not yet reflected in this policy, refer to one of the following policies (a or b): WebSep 5, 2005 · Brief Summary: The main purpose of this study is to evaluate differences in the pharmacodynamic response of 4 Aldurazyme® (laronidase) dose regimens in patients with Mucopolysaccharidosis I (MPS I). Study Design Go to Resource links provided by the National Library of Medicine MedlinePlus Genetics related topics: … WebFind medical information for Aldurazyme on epocrates online, including its dosing, contraindications, drug interactions, and pill pictures. Drugs; Diseases; Interaction Check; Pill ID; Calculators; ... Dosage forms: INJ mucopolysaccharidosis I [6 mo and older] Dose: 0.58 mg/kg/dose IV qwk; Info: for pts w/ Hurler, Hurler-Scheie, and mod-severe ... hard cardio workout at gym